We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QRVO icon
1276
Qorvo
QRVO
$8.68B
$6.18M 0.01%
68,150
-56,225
-45% -$5.08M
LGIH icon
1277
LGI Homes
LGIH
$1.37B
$6.18M 0.01%
66,688
-2,098
-3% -$192K
CCJ icon
1278
Cameco
CCJ
$42.6B
$6.13M 0.01%
270,488
-61,834
-19% -$1.45M
CXT icon
1279
Crane NXT
CXT
$2.96B
$6.12M 0.01%
175,466
-86,126
-33% -$3M
BAR icon
1280
GraniteShares Gold Shares
BAR
$1.46B
$6.11M 0.01%
338,760
+15,628
+5% +$268K
LIT icon
1281
Global X Lithium & Battery Tech ETF
LIT
$1.6B
$6.11M 0.01%
104,295
-4,940
-5% -$330K
DDOG icon
1282
Datadog
DDOG
$90.6B
$6.1M 0.01%
82,967
+7,129
+9% +$557K
DRLL icon
1283
Strive US Energy ETF
DRLL
$302M
$6.08M 0.01%
206,434
+187,515
+991% +$5.54M
LVHD icon
1284
Franklin US Low Volatility High Dividend Index ETF
LVHD
$630M
$6.07M 0.01%
159,623
+68,009
+74% +$2.52M
HLI icon
1285
Houlihan Lokey
HLI
$9.24B
$6.07M 0.01%
69,635
-956
-1% -$85.9K
FIVN icon
1286
FIVE9
FIVN
$2.53B
$6.06M 0.01%
89,310
-7,806
-8% -$490K
SCZ icon
1287
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
$6.05M 0.01%
107,092
-8,806
-8% -$473K
GNW icon
1288
Genworth Financial
GNW
$3.77B
$6.04M 0.01%
1,142,280
+162,195
+17% +$763K
PJT icon
1289
PJT Partners
PJT
$4.57B
$6.04M 0.01%
81,982
+1,507
+2% +$113K
NMRK icon
1290
Newmark Group
NMRK
$2.77B
$6.02M 0.01%
755,806
-65,550
-8% -$547K
CVE icon
1291
Cenovus Energy
CVE
$56.4B
$6.01M 0.01%
309,768
+19,566
+7% +$375K
BHK icon
1292
BlackRock Core Bond Trust
BHK
$661M
$6.01M 0.01%
578,890
+181,396
+46% +$1.9M
REG icon
1293
Regency Centers
REG
$14.1B
$5.99M 0.01%
95,894
-46
-0% -$2.83K
UMH
1294
UMH Properties
UMH
$1.42B
$5.99M 0.01%
371,808
+312,331
+525% +$5.26M
GSUS icon
1295
Goldman Sachs MarketBeta US Equity ETF
GSUS
$3.32B
$5.97M 0.01%
+114,939
New +$6.02M
NET icon
1296
Cloudflare
NET
$118B
$5.96M 0.01%
131,928
-36,172
-22% -$1.79M
XJH icon
1297
iShares ESG Screened S&P Mid-Cap ETF
XJH
$438M
$5.96M 0.01%
181,595
+47,506
+35% +$1.55M
OBDC icon
1298
Blue Owl Capital
OBDC
$5.87B
$5.94M 0.01%
514,659
+24,433
+5% +$293K
HALO icon
1299
Halozyme
HALO
$11.4B
$5.94M 0.01%
104,400
+29,546
+39% +$1.51M
AVTR icon
1300
Avantor
AVTR
$9.37B
$5.91M 0.01%
280,374
-132,659
-32% -$2.75M

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.